Jcog0301 1

jcog0301
jcog0301 Jun 09, 2025 · 0 Comment
Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301) - The Lancet Oncology Jcog0301 By TheLancet.com
Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomis Jcog0301 By The Lancet
Real-world status of multimodal treatment of Stage IIIA-N2 non-small cell lung cancer in Japan: Results from the SOLUTION study, a non-interventional, multicenter cohort study - Lung Cancer Jcog0301 By Lung Cancer
Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trials - Cancer Treatment Reviews Jcog0301 By Cancer Treatment Reviews
Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301). | Semantic Scholar Jcog0301 By Semantic Scholar
Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301). | Semantic Scholar Jcog0301 By Semantic Scholar
Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline | Journal of Clinical Oncology Jcog0301 By ASCO Publications
Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301). | Semantic Scholar Jcog0301 By Semantic Scholar
The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non–Small Cell Lung Cancer - Journal of Thoracic Oncology Jcog0301 By Journal of Thoracic Oncology
A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A - ESMO Jcog0301 By ESMO Open
Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline | Journal of Clinical Oncology Jcog0301 By ASCO Publications
Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline | Journal of Clinical Oncology Jcog0301 By ASCO Publications
Histology-based Combination Induction Chemotherapy for Elderly Patients with Clinical Stage III Non-small Cell Lung Cancer | Anticancer Research Jcog0301 By Anticancer Research
A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study - European Journal of Cancer Jcog0301 By European Journal of Cancer
Management of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline | Journal of Clinical Oncology Jcog0301 By ASCO Publications
Treatment at Twilight: An Analysis of Therapy Patterns and Outcomes in Adults 80 Years and Older With Advanced or Metastatic NSCLC - JTO Clinical and Research Reports Jcog0301 By JTO Clinical and Research Reports

No comments

Your email address will not be published. Required fields are marked *

You might like

© 2025 cheercloset.jp